“...this paper is significant because it provides solid evidence-based data to substantiate that a bariatric surgery procedure – a single intervention – will simultaneously cause resolution not only of excess weight but of the comorbid conditions of type 2 diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea.”

I believe that this paper is highly cited because it is the first and only major meta-analysis of the world literature of bariatric surgery specifically focusing on the effects of bariatric surgery on the comorbid conditions of type 2 diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea.

Though this meta-analysis is not a new discovery or a new methodology, it provides the ever-enlarging community of bariatric surgery with an accurate assessment of operative outcomes, as well as weight loss response and operative mortality.

In layman’s terms, this paper is significant because it provides solid evidence-based data to substantiate that a bariatric surgery procedure—a single intervention—will simultaneously cause resolution not only of excess weight but of the comorbid conditions of type 2 diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea.

Morbid obesity has been a major interest in my research throughout my entire academic career. I performed my first obesity procedure in 1966.